NewAmsterdam Pharma Co N.V 20-F/A for FY2022
NewAmsterdam Pharma Co N.V. (NAMS)
20-F/A
2024-10-28
For: 2022-12-31
View Original
Added on
August 22, 2026
About this 20-F/A
NewAmsterdam Pharma Co N.V filed this 20-F/A on October 28, 2024, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 97.5M EUR
- Net loss
- 78.05M EUR
- compared with a net loss of 28.6M EUR a year earlier
- Diluted EPS
- -1.97 EUR
- compared with -1.21 EUR a year earlier